Craig Eagle Guardant Health, Inc. (GH) insider trading activity

Craig Eagle is Chief Medical Officer of Guardant Health, Inc.. Currently has a direct ownership of 45,007 shares of GH, which is worth approximately $4.25 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 711 shares (Common Stock) at a price of $102.67 per share, resulting in proceeds of $72,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45K

20.08% 3M change

87.83% 12M change

Total Value Held $4.25 Million

CRAIG EAGLE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2025	SELL Payment of exercise price or tax liability	$72,998 $102.67 p/Share	711 Reduced 1.56%	45,007 Common Stock
Dec 15 2025	BUY Exercise of conversion of derivative security	-	1,402 Added 2.98%	45,718 Common Stock
Oct 01 2025	SELL Payment of exercise price or tax liability	$440,116 $62.65 p/Share	7,025 Reduced 13.68%	44,316 Common Stock
Oct 01 2025	BUY Exercise of conversion of derivative security	-	13,859 Added 21.26%	51,341 Common Stock
Sep 15 2025	SELL Payment of exercise price or tax liability	$38,955 $54.79 p/Share	711 Reduced 1.86%	37,482 Common Stock
Sep 15 2025	BUY Exercise of conversion of derivative security	-	1,402 Added 3.54%	38,193 Common Stock
Jul 01 2025	SELL Payment of exercise price or tax liability	$86,916 $50.71 p/Share	1,714 Reduced 4.45%	36,791 Common Stock

Jul 01 2025	BUY Exercise of conversion of derivative security	-	3,381 Added 8.07%	38,505 Common Stock
Jun 15 2025	SELL Payment of exercise price or tax liability	$35,045 $49.29 p/Share	711 Reduced 1.98%	35,124 Common Stock
Jun 15 2025	BUY Exercise of conversion of derivative security	-	1,402 Added 3.77%	35,835 Common Stock
May 15 2025	SELL Payment of exercise price or tax liability	$76,267 $40.46 p/Share	1,885 Reduced 5.19%	34,433 Common Stock
May 15 2025	BUY Exercise of conversion of derivative security	-	3,718 Added 9.29%	36,318 Common Stock
Apr 01 2025	SELL Payment of exercise price or tax liability	$54,998 $42.47 p/Share	1,295 Reduced 3.82%	32,600 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	3,381 Added 9.07%	33,895 Common Stock
Mar 15 2025	SELL Payment of exercise price or tax liability	$21,445 $42.89 p/Share	500 Reduced 1.61%	30,514 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	1,401 Added 4.32%	31,014 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$86,333 $42.55 p/Share	2,029 Reduced 6.41%	29,613 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	5,686 Added 15.23%	31,642 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$42,372 $30.55 p/Share	1,387 Reduced 5.07%	25,956 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	3,381 Added 11.0%	27,343 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$24,714 $34.76 p/Share	711 Reduced 2.88%	23,962 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	1,402 Added 5.38%	24,673 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$92,904 $22.12 p/Share	4,200 Reduced 15.29%	23,271 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	-	8,284 Added 23.17%	27,471 Common Stock
Sep 15 2024	SELL Payment of exercise price or tax liability	$19,047 $26.79 p/Share	711 Reduced 3.57%	19,187 Common Stock

Also insider at

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Director

Craig Eagle

Chief Medical Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account